FDA gives thumbs down to MDMA for now, demanding further research
The much-anticipated decision has rattled supporters of psychedelic therapies. The drugmaker says it will ask the agency to reconsider.
MDMA
Can MDMA still win FDA approval? Supporters rally as time runs out
With support from both sides in Congress, advocates are still fighting to get the psychedelic drug approved as a mental health treatment, despite its rejection by the FDA's advisory committee in June.
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics
Psychedelics researchers and investors are still reeling from last week’s no vote for MDMA by a panel of advisers to the FDA.
As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence
Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.
Psychedelic drugs may launch a new era in psychiatric treatment, brain scientists say
Psychedelic drugs were a hot topic at this year's Society for Neuroscience meeting. Researchers hope the drugs can help people with disorders like depression and PTSD.
Psychiatrist Explores Possible Benefits Of Treating PTSD With Ecstasy Or Cannabis
Dr. Julie Holland thinks psychedelic drugs can be used in psychiatry to make treatment more efficient and effective. "This is sort of a new paradigm," she says, "a revolutionary way to treat trauma."
MDMA, Or Ecstasy, Shows Promise As A PTSD Treatment
Drugs like molly and ecstasy may be best known for giving partyers euphoric feelings. But MDMA, the drugs' psychoactive ingredient, is proving effective at treating severe trauma when used in therapy.
Making Sure Ecstasy Is Ecstasy: Volunteers Test Drugs At U.K. Music Fests
This summer, the first stop for many U.K. partiers will be a special tent where, without fear of arrest, they can get their illegal drugs tested for potency and makeup to prevent overdoses.